Role of the vaginally administered aromatase inhibitor anastrozole in women with rectovaginal endometriosis: a pilot study
Authors:
- Friedrich NageleFNFriedrich Nagele
- 1 October 2005
- journal article
- research article
- Published by Elsevier in Fertility and Sterility
- Vol. 84 (4) , 1033-1036
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Single-dose administration of an aromatase inhibitor for ovarian stimulationFertility and Sterility, 2005
- Why consider vaginal drug administration?Fertility and Sterility, 2004
- Successful treatment of severe endometriosis in two premenopausal women with an aromatase inhibitorFertility and Sterility, 2004
- Treatment of endometriosis and chronic pelvic pain with letrozole and norethindrone acetate: a pilot studyFertility and Sterility, 2004
- Treatment of severe recurrent endometriosis with an aromatase inhibitor in a young ovariectomised womanBJOG: An International Journal of Obstetrics & Gynaecology, 2004
- Treatment of EndometriosisNew England Journal of Medicine, 2001
- Estrogen biosynthesis in endometriosis: molecular basis and clinical relevanceJournal of Molecular Endocrinology, 2000
- Estrogen production in endometriosis and use of aromatase inhibitors to treat endometriosis.Endocrine-Related Cancer, 1999
- Treatment of Severe Postmenopausal Endometriosis With an Aromatase InhibitorFertility and Sterility, 1998
- Tissue Factors Influencing Growth and Maintenance of EndometriosisaAnnals of the New York Academy of Sciences, 1991